Olympus Corporation Clinical I is categorized under Electronic Photographic Instruments in Dallas, TX and active since 2000.
Olympus Corporation Clinical I was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Electronic Photographic Instruments business, which does work in the BOTH market, and is classified as a Electronic Photographic Instruments, under code number 333316 by the NAICS.
If you are seeking more information, feel free to contact Hiroshi Sekiya at the company’s single location by writing to 3131 Royal Lane, Dallas, Texas TX 75229 or by phoning (972) 556-9697. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Olympus Corporation Clinical I |
| Contact Person: | Hiroshi Sekiya |
| Address: | 3131 Royal Lane, Dallas, Texas 75229 |
| Phone Number: | (972) 556-9697 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Electronic Photographic Instruments |
| SIC Code: | 3861 |
| NAICS Code: | 333316 |
| Share This Business: |
Olympus Corporation Clinical I was started in 2000 to provide professional Electronic Photographic Instruments under the SIC code 3861 and NAICS code 333316. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Hiroshi Sekiya for inquiries that concern Olympus Corporation Clinical I by calling the company number (972) 556-9697, as your correspondence is most welcome. Additionally, the physical location of the single location of Olympus Corporation Clinical I can be found at the coordinates 32.895365,-96.873994 as well as the street address 3131 Royal Lane in Dallas, Texas 75229.
For its online presence, you may visit Olympus Corporation Clinical I’s website at and engage with its social media outlets through on Twitter and on Facebook.